Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 54.15
+0.54 (1.01%)
At close: Sep 4, 2026
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 111.44M CNY in the quarter ending June 30, 2026, with 32.55% growth. This brings the company's revenue in the last twelve months to 400.85M, up 27.59% year-over-year. In the year 2025, Medprin Regenerative Medical Technologies had annual revenue of 368.83M with 32.46% growth.
Revenue (ttm)
400.85M
Revenue Growth
+27.59%
P/S Ratio
9.01
Revenue / Employee
896.77K
Employees
447
Market Cap
3.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 368.83M | 90.39M | 32.46% |
| Dec 31, 2024 | 278.44M | 47.57M | 20.61% |
| Dec 31, 2023 | 230.87M | 35.62M | 18.24% |
| Jan 1, 2023 | 195.25M | 41.47M | 26.96% |
| Jan 1, 2022 | 153.79M | 30.27M | 24.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.09B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Guangdong Transtek Medical Electronics | 999.28M |
| Shanghai Aohua Photoelectricity Endoscope | 793.05M |
| Ningbo David Medical Device | 584.68M |
| Chison Medical Technologies | 441.10M |
| Shanghai General Healthy Information and Technology | 371.61M |
| CareRay Digital Medical Technology | 319.79M |